Variant report
Variant | nsv998153 |
---|---|
Chromosome Location | chr2:53005501-53033534 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs2603393 | chr2:53005501-53005502 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs369990091 | chr2:53005512-53005513 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs529114937 | chr2:53005547-53005548 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs189345078 | chr2:53005551-53005552 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs529848797 | chr2:53005566-53005567 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs568910705 | chr2:53005579-53005580 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs371776334 | chr2:53005623-53005624 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs1454388 | chr2:53005638-53005639 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs180787863 | chr2:53005679-53005680 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs186225840 | chr2:53005716-53005717 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs534310658 | chr2:53005730-53005731 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs554174660 | chr2:53005740-53005741 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs191004866 | chr2:53005748-53005749 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs2599286 | chr2:53005758-53005759 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs73931462 | chr2:53005790-53005791 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs576702453 | chr2:53005825-53005826 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs545179158 | chr2:53005826-53005827 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs181927936 | chr2:53005861-53005862 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs532832432 | chr2:53005910-53005911 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs62127030 | chr2:53005913-53005914 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs140577531 | chr2:53005931-53005932 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs149690332 | chr2:53005954-53005955 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs548589050 | chr2:53006004-53006005 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs185930369 | chr2:53006041-53006042 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs562787167 | chr2:53006072-53006073 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs531536668 | chr2:53006073-53006074 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs1451464 | chr2:53006126-53006127 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
28 | rs1451465 | chr2:53006142-53006143 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs1454387 | chr2:53006197-53006198 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs547913614 | chr2:53006234-53006235 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs567699568 | chr2:53006250-53006251 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs536639669 | chr2:53006301-53006302 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs1451466 | chr2:53006336-53006337 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs576650226 | chr2:53006374-53006375 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs369772425 | chr2:53006396-53006397 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs538966256 | chr2:53006397-53006398 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs558688009 | chr2:53006400-53006401 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs139135328 | chr2:53021825-53021826 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs189781796 | chr2:53021829-53021830 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs543480240 | chr2:53021837-53021838 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs75051235 | chr2:53021846-53021847 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs572615265 | chr2:53021909-53021910 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs551145063 | chr2:53021921-53021922 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs571431333 | chr2:53021925-53021926 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs546380684 | chr2:53021943-53021944 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs559993597 | chr2:53021965-53021966 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs533707766 | chr2:53021992-53021993 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs371168552 | chr2:53022057-53022058 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs73931478 | chr2:53022059-53022060 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs115015794 | chr2:53022070-53022071 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 16272173 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Lung cancer | 17086460 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:53004200-53006400 | Enhancers | Fetal Intestine Large | intestine |
2 | chr2:53021800-53022200 | Enhancers | Adipose Nuclei | Adipose |
3 | chr2:53024200-53025200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
4 | chr2:53025200-53029200 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
5 | chr2:53027800-53049000 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
6 | chr2:53029200-53029400 | ZNF genes & repeats | ES-WA7 Cell Line | embryonic stem cell |
7 | chr2:53029200-53029800 | ZNF genes & repeats | Foreskin Melanocyte Primary Cells skin03 | Skin |
8 | chr2:53029800-53033200 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
9 | chr2:53031200-53031800 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
10 | chr2:53031400-53031800 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
11 | chr2:53033200-53034400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |